Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019-Reference-Cited by-同舟云学术

Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019

Published:2020-06-04 Issue:16 Volume:126 Page:3742-3749
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Desai Aakash P.¹^ORCID,Chengappa Madhuri²,Go Ronald S.³^ORCID,Poonacha Thejaswi K.⁴^ORCID

Affiliation:

1. Department of Medicine University of Connecticut Farmington Connecticut

2. Department of Medicine Nazareth Hospital Philadelphia Pennsylvania

3. Division of Hematology Department of Internal Medicine Mayo Clinic Rochester Minnesota

4. Department of Internal Medicine University of Minnesota Medical Center Minneapolis Minnesota

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32997

Reference21 articles.

1. National Comprehensive Cancer Network.About the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Accessed April 12 2019.https://www.nccn.org/professionals/default.aspx

2. Conflicts of interest in medicine: taking diversity seriously

3. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study;JCO Global Oncology;2024-07

2. Industry relationships with interventional radiologists: Who are the high payment physicians?;Current Problems in Diagnostic Radiology;2024-07

3. Financial Conflicts of Interest: Payment at the Expense of Patients?;JCO Oncology Practice;2024-06

4. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set;JCO Oncology Practice;2024-06

5. Pharmaceutical company payments to Japanese breast cancer practice guideline authors;Clinical and Translational Discovery;2024-06